Guardant Health Inc
NASDAQ:GH

Watchlist Manager
Guardant Health Inc Logo
Guardant Health Inc
NASDAQ:GH
Watchlist
Price: 47.5 USD -0.65% Market Closed
Market Cap: 5.9B USD

Wall Street
Price Targets

GH Price Targets Summary
Guardant Health Inc

Wall Street analysts forecast GH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GH is 59.6 USD with a low forecast of 20.2 USD and a high forecast of 73.5 USD.

Lowest
Price Target
20.2 USD
57% Downside
Average
Price Target
59.6 USD
25% Upside
Highest
Price Target
73.5 USD
55% Upside
Guardant Health Inc Competitors:
Price Targets
4544
H.U. Group Holdings Inc
5% Downside
PINC
Premier Inc
8% Upside
CCRN
Cross Country Healthcare Inc
49% Upside
4694
BML Inc
26% Upside
AHX
Apiam Animal Health Ltd
13% Upside
DGX
Quest Diagnostics Inc
12% Upside
VVOS
Vivos Therapeutics Inc
29% Downside
KRSNAA
Krsnaa Diagnostics Ltd
22% Upside

Revenue
Forecast

Revenue Estimate
Guardant Health Inc

For the last 7 years the compound annual growth rate for Guardant Health Inc's revenue is 47%. The projected CAGR for the next 3 years is 23%.

47%
Past Growth
23%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Guardant Health Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
Guardant Health Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-16%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GH's stock price target?
Price Target
59.6 USD

According to Wall Street analysts, the average 1-year price target for GH is 59.6 USD with a low forecast of 20.2 USD and a high forecast of 73.5 USD.

What is Guardant Health Inc's Revenue forecast?
Projected CAGR
23%

For the last 7 years the compound annual growth rate for Guardant Health Inc's revenue is 47%. The projected CAGR for the next 3 years is 23%.

Back to Top